Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
BMJ Case Reports
|
September 24, 2016
Safety and efficacy of pembrolizumab in a patient with advanced melanoma on haemodialysis
Rubens Chang, Keisuke Shirai
American Journal of Clinical Oncology
|
February 8, 2011
Systemic therapy for squamous cell carcinoma of the skin in organ transplant recipients
James Leroy Wells, Keisuke Shirai
Current Treatment Options in Oncology
|
October 27, 2007
Molecular targets in squamous cell carcinoma of the head and neck
Keisuke Shirai, Paul E O'Brien
Thescientificworldjournal
|
July 11, 2007
Use of low molecular weight heparin and aminocaproic acid in chronic DIC associated with prostate cancer--a case report
Keisuke Shirai, Uzair B Chaudhary
Melanoma Research
|
May 12, 2018
Immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy alone versus immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy in combination with anti-RANKL denosumuab in malignant melanoma: a retrospective analysis at a tertiary care center
Muhammad Z Afzal, Keisuke Shirai
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 2, 2019
Response to the Rechallenge With Talimogene Laherparepvec (T-VEC) After Ipilimumab/Nivolumab Treatment in Patient With Cutaneous Malignant Melanoma Who Initially Had a Progression on T-VEC With Pembrolizumab
Muhammad Z Afzal, Keisuke Shirai
Advances in Experimental Medicine and Biology
|
December 16, 2015
Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer
Sai-Hong Ignatius Ou, Keisuke Shirai
Transplant Immunology
|
September 21, 2023
Durable complete response to early immunotherapy discontinuation in a kidney transplant recipient with advanced cutaneous squamous cell carcinoma: A case report and review of literature
Ziyao Lu, Muhammad Afzal, Keisuke Shirai
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 31, 2019
Prognostic Significance of Hematological Indices in Malignant Melanoma Treated With Immune Checkpoint Inhibitors
Muhammad Z Afzal, Tayyaba Sarwar, Keisuke Shirai
Journal of Thoracic Disease
|
August 3, 2018
A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer
Muhammad Zubair Afzal, Konstantin Dragnev, Keisuke Shirai
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
BMJ Case Reports
|
September 24, 2016
Safety and efficacy of pembrolizumab in a patient with advanced melanoma on haemodialysis
Rubens Chang, Keisuke Shirai
American Journal of Clinical Oncology
|
February 8, 2011
Systemic therapy for squamous cell carcinoma of the skin in organ transplant recipients
James Leroy Wells, Keisuke Shirai
Current Treatment Options in Oncology
|
October 27, 2007
Molecular targets in squamous cell carcinoma of the head and neck
Keisuke Shirai, Paul E O'Brien
Thescientificworldjournal
|
July 11, 2007
Use of low molecular weight heparin and aminocaproic acid in chronic DIC associated with prostate cancer--a case report
Keisuke Shirai, Uzair B Chaudhary
Melanoma Research
|
May 12, 2018
Immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy alone versus immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy in combination with anti-RANKL denosumuab in malignant melanoma: a retrospective analysis at a tertiary care center
Muhammad Z Afzal, Keisuke Shirai
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 2, 2019
Response to the Rechallenge With Talimogene Laherparepvec (T-VEC) After Ipilimumab/Nivolumab Treatment in Patient With Cutaneous Malignant Melanoma Who Initially Had a Progression on T-VEC With Pembrolizumab
Muhammad Z Afzal, Keisuke Shirai
Advances in Experimental Medicine and Biology
|
December 16, 2015
Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer
Sai-Hong Ignatius Ou, Keisuke Shirai
Transplant Immunology
|
September 21, 2023
Durable complete response to early immunotherapy discontinuation in a kidney transplant recipient with advanced cutaneous squamous cell carcinoma: A case report and review of literature
Ziyao Lu, Muhammad Afzal, Keisuke Shirai
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 31, 2019
Prognostic Significance of Hematological Indices in Malignant Melanoma Treated With Immune Checkpoint Inhibitors
Muhammad Z Afzal, Tayyaba Sarwar, Keisuke Shirai
Journal of Thoracic Disease
|
August 3, 2018
A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer
Muhammad Zubair Afzal, Konstantin Dragnev, Keisuke Shirai
Page
of 9